Search Results - "de Wildt, S"

Refine Results
  1. 1

    Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group by Brouwer, KLR, Aleksunes, LM, Brandys, B, Giacoia, GP, Knipp, G, Lukacova, V, Meibohm, B, Nigam, SK, Rieder, M, de Wildt, SN

    Published in Clinical pharmacology and therapeutics (01-09-2015)
    “…The critical importance of membrane‐bound transporters in pharmacotherapy is widely recognized, but little is known about drug transporter activity in…”
    Get full text
    Journal Article
  2. 2

    Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species by van Groen, B D, Nicolaï, J, Kuik, A C, Van Cruchten, S, van Peer, E, Smits, A, Schmidt, S, de Wildt, S N, Allegaert, K, De Schaepdrijver, L, Annaert, P, Badée, J

    Published in Pharmacological reviews (01-04-2021)
    “…The liver represents a major eliminating and detoxifying organ, determining exposure to endogenous compounds, drugs, and other xenobiotics. Drug transporters…”
    Get full text
    Journal Article
  3. 3

    Willingness-to-use and preferences for model-informed antenatal doses: a cross-sectional study among European healthcare practitioners and pregnant women by Koldeweij, C J M, Dibbets, A C, Ceulemans, M, de Vries, L C, Franklin, B D, Scheepers, H C J, de Wildt, S N

    Published in Frontiers in pharmacology (15-08-2024)
    “…Physiological changes in pregnancy may affect drug safety and efficacy, sometimes requiring dose adjustments. Pregnancy-adjusted doses, however, are missing…”
    Get full text
    Journal Article
  4. 4

    Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development by Burt, T, Yoshida, K, Lappin, G, Vuong, L, John, C, Wildt, SN, Sugiyama, Y, Rowland, M

    Published in Clinical and translational science (01-04-2016)
    “…A number of drivers and developments suggest that microdosing and other phase 0 applications will experience increased utilization in the near-to-medium…”
    Get full text
    Journal Article
  5. 5

    Pharmacotherapy in neonatal and pediatric extracorporeal membrane oxygenation (ECMO) by Wildschut, E D, Ahsman, M J, Houmes, R J, Pokorna, P, de Wildt, S N, Mathot, R A A, Tibboel, D

    Published in Current drug metabolism (01-07-2012)
    “…ECMO support is an established life saving therapy for potentially reversible respiratory and/or cardiac failure. Improvement of outcome depends on effective…”
    Get more information
    Journal Article
  6. 6

    Glucuronidation in humans : Pharmacogenetic and developmental aspects by DE WILDT, S. N, KEARNS, G. L, LEEDER, J. S, VAN DEN ANKER, J. N

    Published in Clinical pharmacokinetics (01-06-1999)
    “…During human development impressive changes in drug disposition occur. An important determinant of drug clearance is metabolism, something that is not only…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients by de Wildt, S N, de Hoog, M, Vinks, A A, van der Giesen, E, van den Anker, J N

    Published in Critical care medicine (01-07-2003)
    “…OBJECTIVETo determine the pharmacokinetics and metabolism of midazolam in pediatric intensive care patients. DESIGNProspective population pharmacokinetic…”
    Get full text
    Journal Article
  10. 10

    Protocolized post-operative pain management in infants; do we stick to it? by Ceelie, I., de Wildt, S.N., de Jong, M., Ista, E., Tibboel, D., van Dijk, M.

    Published in European journal of pain (01-05-2012)
    “…Background The American Academy of Pediatrics states that ongoing assessment of pain is essential for adequate pain treatment. Pain assessment by means of the…”
    Get full text
    Journal Article
  11. 11

    Feasibility of sedation and analgesia interruption following cannulation in neonates on extracorporeal membrane oxygenation by Wildschut, E. D., Hanekamp, M. N., Vet, N. J., Houmes, R. J., Ahsman, M. J., Mathot, R. A. A., de Wildt, S. N., Tibboel, D.

    Published in Intensive care medicine (01-09-2010)
    “…Purpose In most extracorporeal membrane oxygenation (ECMO) centers patients are heavily sedated to prevent accidental decannulation and bleeding complications…”
    Get full text
    Journal Article
  12. 12

    Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy by Workum, J D, Kramers, C, Kolwijck, E, Schouten, J A, de Wildt, S N, Brüggemann, R J

    Published in Journal of antimicrobial chemotherapy (01-01-2021)
    “…Piperacillin/tazobactam combined with vancomycin has been associated with a decline in renal function when compared with monotherapy. Teicoplanin is a…”
    Get full text
    Journal Article
  13. 13

    Pharmacokinetics and metabolism of oral midazolam in preterm infants by De Wildt, S. N., Kearns, G. L., Hop, W. C. J., Murry, D. J., Abdel‐Rahman, S. M., Van Den Anker, J. N.

    Published in British journal of clinical pharmacology (01-04-2002)
    “…Aims  To characterize the pharmacokinetics and metabolism of oral midazolam in 15 preterm infants. Methods  After an oral dose (0.1 mg kg−1), blood was drawn…”
    Get full text
    Journal Article
  14. 14

    Developmental patterns in human blood–brain barrier and blood–cerebrospinal fluid barrier ABC drug transporter expression by Verscheijden, L. F. M., van Hattem, A. C., Pertijs, J. C. L. M., de Jongh, C. A., Verdijk, R. M., Smeets, B., Koenderink, J. B., Russel, F. G. M., de Wildt, S. N.

    Published in Histochemistry and cell biology (01-09-2020)
    “…When drugs exert their effects in the brain, linear extrapolation of doses from adults could be harmful for children as the blood–brain barrier (BBB) and…”
    Get full text
    Journal Article
  15. 15

    Cytochrome P450 3A: Ontogeny and drug disposition by DE WILDT, S. N, KEARNS, G. L, LEEDER, J. S, VAN DEN ANKER, J. N

    Published in Clinical pharmacokinetics (01-12-1999)
    “…The maturation of organ systems during fetal life and childhood exerts a profound effect on drug disposition. The maturation of drug-metabolising enzymes is…”
    Get full text
    Journal Article
  16. 16

    Pediatric microdose and microtracer studies using 14C in Europe by Turner, MA, Mooij, MG, Vaes, WHJ, Windhorst, AD, Hendrikse, NH, Knibbe, CAJ, Kõrgvee, LT, Maruszak, W, Grynkiewicz, G, Garner, RC, Tibboel, D, Park, BK, de Wildt, SN

    Published in Clinical pharmacology and therapeutics (01-09-2015)
    “…Important information gaps remain on the efficacy and safety of drugs in children. Pediatric drug development encounters several ethical, practical, and…”
    Get full text
    Journal Article
  17. 17

    The COMFORT behaviour scale detects clinically meaningful effects of analgesic and sedative treatment by Boerlage, A.A., Ista, E., Duivenvoorden, H.J., de Wildt, S.N., Tibboel, D., van Dijk, M.

    Published in European journal of pain (01-04-2015)
    “…Background The COMFORT behaviour scale (COMFORT‐B scale) is widely used in paediatric intensive care units to assess young children's pain and distress. It is…”
    Get full text
    Journal Article
  18. 18

    Human Intestinal PEPT1 Transporter Expression and Localization in Preterm and Term Infants by Mooij, Miriam G, de Koning, Barbara E A, Lindenbergh-Kortleve, Dicky J, Simons-Oosterhuis, Ytje, van Groen, Bianca D, Tibboel, Dick, Samsom, Janneke N, de Wildt, Saskia N

    Published in Drug metabolism and disposition (01-07-2016)
    “…The intestinal influx oligopeptide transporter peptide transporter 1 (PEPT1) (SLC15A1) is best known for nutrient-derived di- and tripeptide transport. Its…”
    Get full text
    Journal Article
  19. 19
  20. 20